Follow
Borwin Bandelow
Borwin Bandelow
Professor for Psychiatry and Psychotherapy, University of Göttingen
Verified email at gwdg.de
Title
Cited by
Cited by
Year
Epidemiology of anxiety disorders in the 21st century
B Bandelow, S Michaelis
Dialogues in clinical neuroscience, 2022
16922022
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders …
B Bandelow, J Zohar, E Hollander, S Kasper, HJ Möller, ...
The World Journal of Biological Psychiatry 9 (4), 248-312, 2008
8912008
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology
DS Baldwin, IM Anderson, DJ Nutt, B Bandelow, A Bond, JRT Davidson, ...
Journal of Psychopharmacology 19 (6), 567-596, 2005
7442005
Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the …
DS Baldwin, IM Anderson, DJ Nutt, C Allgulander, B Bandelow, ...
Journal of Psychopharmacology 28 (5), 403-439, 2014
6322014
Treatment of anxiety disorders
B Bandelow, S Michaelis, D Wedekind
Dialogues in clinical neuroscience, 2022
6142022
Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder
A Broocks, B Bandelow, G Pekrun, A George, T Meyer, U Bartmann, ...
American Journal of Psychiatry 155 (5), 603-609, 1998
5431998
Efficacy of treatments for anxiety disorders: a meta-analysis
B Bandelow, M Reitt, C Röver, S Michaelis, Y Görlich, D Wedekind
International clinical psychopharmacology 30 (4), 183-192, 2015
5162015
Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with borderline personality disorder and healthy controls
B Bandelow, J Krause, D Wedekind, A Broocks, G Hajak, E Rüther
Psychiatry research 134 (2), 169-179, 2005
4372005
Guidelines for the pharmacological treatment of anxiety disorders, obsessive–compulsive disorder and posttraumatic stress disorder in primary care
B Bandelow, L Sher, R Bunevicius, E Hollander, S Kasper, J Zohar, ...
International journal of psychiatry in clinical practice 16 (2), 77-84, 2012
4302012
Assessing the efficacy of treatments for panic disorder and agoraphobia: II. The Panic and Agoraphobia Scale.
B Bandelow
International clinical psychopharmacology, 1995
4171995
Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition
B Bandelow, D Baldwin, M Abelli, B Bolea-Alamanac, M Bourin, ...
The World Journal of Biological Psychiatry 18 (3), 162-214, 2017
2692017
WFSBP Task Force on Treatment Guidelines for Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders: World Federation of Societies of Biological Psychiatry (WFSBP …
B Bandelow, J Zohar, E Hollander, S Kasper, HJ Möller
World J Biol Psychiatry 9 (4), 248-312, 2008
2532008
Meta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disorders
B Bandelow, U Seidler-Brandler, A Becker, D Wedekind, E Rüther
The World Journal of Biological Psychiatry 8 (3), 175-187, 2007
2352007
Early traumatic life events, parental rearing styles, family history of mental disorders, and birth risk factors in patients with social anxiety disorder
B Bandelow, A Charimo Torrente, D Wedekind, A Broocks, G Hajak, ...
European archives of psychiatry and clinical neuroscience 254 (6), 397-405, 2004
2352004
What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?
B Bandelow, DS Baldwin, OT Dolberg, HF Andersen, DJ Stein
The Journal of clinical psychiatry 67 (9), 10019, 2006
2292006
Neuropeptide S receptor gene—converging evidence for a role in panic disorder
K Domschke, A Reif, H Weber, J Richter, C Hohoff, P Ohrmann, ...
Molecular psychiatry 16 (9), 938-948, 2011
2072011
Panic and Agoraphobia Scale (PAS).
B Bandelow
Hogrefe & Huber Publishers, 1999
1991999
Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with panic disorder
B Bandelow, C Späth, GÁ Tichauer, A Broocks, G Hajak, E Rüther
Comprehensive psychiatry 43 (4), 269-278, 2002
1912002
Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo-and …
B Bandelow, G Chouinard, J Bobes, A Ahokas, I Eggens, S Liu, ...
The The International Journal of Neuropsychopharmacology 13 (3), 305-320, 2010
1742010
TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies
A Erhardt, L Czibere, D Roeske, S Lucae, PG Unschuld, S Ripke, ...
Molecular psychiatry 16 (6), 647-663, 2011
1702011
The system can't perform the operation now. Try again later.
Articles 1–20